500 White Plains Road

Tarrytown, New York
  • Sale Price Unpriced
  • Property Type Lab/R&D
  • Square Feet 153,168± SF 
  • Acreage 16.17± Acres

Property Flyer

Offering Memorandum

Matthew Torrance  •  Senior Director
matthew.torrance@cushwake.com

203.326.5838

Al Mirin  •  Ex. Managing Director
al.mirin@cushwake.com
203.326.5822

David Bernhaut  •  Ex. Vice Chairman
david.bernhaut@cushwake.com

201.460.3356

Frank DiTommaso  •  Ex. Man. Director
frank.ditommaso@cushwake.com

201.508.5303

Brian Anderson  •  Ex. Managing Director
brian.anderson@cushwake.com
732.616.0908

Chuck Kohaut  •  Senior Director
chuck.kohaut@cushwake.com

201.528.2154

Matthew Lisk  •  Executive Director
matthew.lisk@cushwake.com

914.305.9303

Tara Long  •  Senior Director
tara.long@cushwake.com

203.326.5886

Cushman & Wakefield, as exclusive advisor, is pleased to present the opportunity to acquire 500 White Plains Road, a 153,168 SF institutional-quality research and development facility located within Tarrytown Corporate Center in Tarrytown, New York.

Purpose-built in 1997 for Ciba Specialty Chemicals and subsequently occupied by BASF following its acquisition of Ciba, 500 White Plains Road has served as one of BASF’s seven North American research and development hubs and represents one of the most sophisticated laboratory assets in the Westchester County market. The Property is currently 90.1% leased to five laboratory and research tenants led by BASF (124,726 SF | 5/31/2027) alongside Sapience Therapeutics, DigiChem Corporation, Nomi Materials and Synko Pharma. The existing tenancy provides stable in-place cash flow, with significant upside upon BASF’s lease expiration in May 2027. The resulting vacancy creates a compelling opportunity to reposition or re-tenant the property, while also offering a unique owner-user occupancy opportunity.

Unlike traditional office buildings, 500 White Plains Road was specifically designed to support advanced research operations and features highly specialized infrastructure including laboratory-ready floor plates, significant mechanical and electrical capacity, emergency generation, loading facilities and sophisticated HVAC systems. Replicating an asset of this caliber today would require substantial capital investment and a lengthy development timeline, positioning the Property as a highly attractive alternative to new construction.

Strategically located immediately off Interstate 287 at the eastern approach to the Mario M. Cuomo Bridge, the Property benefits from exceptional regional accessibility and sits within one of the Northeast’s most established innovation corridors. The surrounding market is anchored by leading healthcare, pharmaceutical and technology organizations including Regeneron, Westchester Medical Center, Montefiore Health System and New York Medical College, providing long-term demand drivers for specialized research and development facilities.

With in-place income, multiple repositioning strategies and infrastructure that would be difficult and costly to replicate today, 500 White Plains Road offers investors and occupiers a compelling opportunity to capitalize on one of the region’s most unique institutional-quality R&D facilities.

  • Institutional-Quality R&D Facility
  • Purpose-Built Laboratory Infrastructure
  • Replacement Cost Advantage
  • Flexible Repositioning Potential
  • Exceptional Regional Connectivity

Property Flyer

Offering Memorandum

Site Plan

500 White Plains Road, Tarrytown, NY